Open AccessApproaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions
Author(s) -
Matthew A Spinelli,
Jessica Haberer,
Peter R. Chai,
José CastilloMancilla,
Peter L. Anderson,
Monica Gandhi
Publication year - 2020
Publication title -
current hiv/aids reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.135
H-Index - 56
eISSN - 1548-3576
pISSN - 1548-3568
DOI - 10.1007/s11904-020-00502-5
Subject(s) - emtricitabine , medicine , pill , antiretroviral medication , dosing , viral load , antiretroviral therapy , efavirenz , medication adherence , pharmacy , psychological intervention , human immunodeficiency virus (hiv) , intensive care medicine , pharmacology , immunology , family medicine , psychiatry
Traditional methods to assess antiretroviral adherence, such as self-report, pill counts, and pharmacy refill data, may be inaccurate in determining actual pill-taking to both antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP). HIV viral loads serve as surrogates of adherence on ART, but loss of virologic control may occur well after decreases in adherence and viral loads are not relevant to PrEP.